Germany's Merck KGaA is looking to sell its $1 billion consumer healthcare unit after a group-wide strategic review.
US regulators have placed on hold studies of French drugmaker Cellectis’ CAR-T therapy following a patient fatality.
The US Food and Drug Administration (FDA) has cleared Adherium for its new inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler.
Medical technology firm Hologic has introduced new Brevera breast biopsy system with CorLumina imaging technology in the US.
MicroPort Orthopedics has launched its new Procotyl Prime Acetabular Cup System, following 510(k) clearance from the US Food and Drug Administration in June.
Resonetics announced today its acquisition of Aduro Laser, an emerging leader in laser processing of tubular components for the medical device industry.
Collaboration on an oncology drug discovery program was inked between Takeda Pharmaceutical, through its subsidiary Millennium Pharmaceuticals, and Molecular Templates.
A distribution agreement for Align’s iTero Element intraoral scanning system has been signed between Patterson Dental, a business unit of Patterson Companies, and Align Technology.
Cel-Sci said today that for a Phase III trial of its investigational immunotherapy, it inked an agreement with institutional investors for a $3.5 million registered direct offering.
Biotronik has secured approval from the US Food and Drug Admini(FDA) for its Edora HF-T QP, a MR conditional quadripolar (QP) cardiac resynchronization therapy pacemaker (CRT-P).
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.